iHuman
7 hedge funds and large institutions have $333K invested in iHuman in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0.1% less ownership
Funds ownership: 0.32% → 0.23% (-0.1%)
20% less capital invested
Capital invested by funds: $415K → $333K (-$82.7K)
22% less funds holding
Funds holding: 9 → 7 (-2)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$266 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$53.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$51K |
| 3 |
Morgan Stanley
New York
|
-$15.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.5K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$2.05K |
IH Hedge Fund Activity: Q3 2025 in Review
7 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q3 2025, worth a combined $333K — down 20% from $415K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IH and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was BlackRock, adding an estimated $266. The largest seller was Citadel Advisors, cutting an estimated $53.3K.
- 7 institutional investors held iHuman (IH) as of Q3 2025, down from 9 in Q2 2025.
- Funds reported $333K of iHuman stock for Q3 2025, down 20% quarter-over-quarter.
- 0 funds opened new iHuman positions in Q3 2025 and 2 closed out, a net change of -2 holders.
- The largest iHuman buyer in Q3 2025 was BlackRock, an estimated $266 added.
- The largest iHuman seller in Q3 2025 was Citadel Advisors, an estimated $53.3K sold.
Based on aggregated 13F filings for Q3 2025.